Results 151 to 160 of about 11,242 (227)

Carbon Ion Radiotherapy for Prostate Cancer

Carbon Ion Radiotherapy for Prostate Cancer
NIRS-MedAustron Jojint Symposium on Carbon Ion Therapy in ...
openaire   +1 more source

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol. [PDF]

BMJ Open
Koroki K, Wakatsuki M, Ogasawara S, Makishima H, Watabe T, Anzai H, Fujiya M, Sawada M, Tsuchiya T, Katayama K, Yoshino R, Izai R, Akatsuka T, Miwa C, Yonemoto T, Yumita S, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Takahashi K, Ozawa Y, Inaba Y, Kurokawa T, Isozaki T, Takahashi A, Kato J, Ohtsuka M, Ohno T, Ueno Y, Furuse J, Kudo M, Hanaoka H, Ishikawa H.   +33 more
europepmc   +1 more source

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial. [PDF]

JHEP Rep
Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Fujiya M, Yumita S, Nakagawa M, Kanzaki H, Kobayashi K, Inoue M, Nakamura M, Kanogawa N, Kondo T, Nakamoto S, Kurokawa T, Ozawa Y, Inaba Y, Paritala S, Chen J, Lee J, Hoshida Y, Hanaoka H, Yamada S, Ishikawa H.   +24 more
europepmc   +1 more source

BCOR-CCNB3 fusion-positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up. [PDF]

Front Oncol
Oike N, Imai R, Ogose A, Ariizumi T, Murayama Y, Miyazaki T, Kimura K, Umezu H, Kawashima H.   +8 more
europepmc   +1 more source

Evaluation of Magnetic Resonance Imaging-Derived Synthetic Computed Tomography in Prostate Cancer Carbon Ion Radiotherapy: Impact of Fixation Shell. [PDF]

Int J Part Ther
Ishizawa M, Haga K, Sato H, Miyasaka Y, Souda H, Chai H, Iwai T.   +6 more
europepmc   +1 more source

Development and validation of NTCP models for predicting acute esophagitis in carbon ion radiotherapy for thoracic malignancies. [PDF]

BMC Cancer
Li Y, Zhang L, Liu Y, Ma N, Wu KL, Mao J, Chen J.   +6 more
europepmc   +1 more source

AI-based prediction of recurrence after carbon ion radiotherapy for early stage non-small cell lung cancer. [PDF]

PLoS One
Miyasaka Y, Yoshida H, Okano N, Shimada H, Kubo N, Kawamura H, Ohno T.   +6 more
europepmc   +1 more source

Fatal Refractory Radiation-Induced Biliary Stenosis (RIBS) and Liver Abscess Following Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: A Case Report. [PDF]

Cureus
Kidogawa H, Tagami T, Yamayoshi T, Noguchi J, Okamoto K.   +4 more
europepmc   +1 more source

Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma. [PDF]

Hepatol Commun
Hatanaka T, Shibuya K, Kakizaki S, Hiraoka A, Tada T, Kariyama K, Itobayashi E, Tsuji K, Ishikawa T, Toyoda H, Koshiyama Y, Naganuma A, Miyasaka Y, Kanayama Y, Tanaka K, Tada F, Ohama H, Nouso K, Nakamura S, Kumada T, Ohno T, Real-life Practice Experts for HCC (RELPEC) Study Group.   +21 more
europepmc   +1 more source

Clinical advantages of carbon-ion radiotherapy

Clinical advantages of carbon-ion radiotherapy
Carbon-ion radiotherapy(C-ion RT)possesses physical and biological advantages. It was started at NIRS in 1994 using the Heavy Ion Medical Accelerator in Chiba(HIMAC); since then more than 50 protocol studies have been conducted on almost 4000 patients with avariety of tumors.
openaire